Acetylcholine receptor antagonists in acute respiratory distress syndrome: much more than muscle relaxants

Crit Care. 2018 May 22;22(1):132. doi: 10.1186/s13054-018-1979-z.

Abstract

Acetylcholine receptor antagonists have been shown to improve outcome in patients with severe acute respiratory distress syndrome. However, it is incompletely understood how these agents improve outcome. In the current editorial, we discuss the mechanisms of action of acetylcholine receptor antagonists beyond neuromuscular blockade.

Keywords: Acetylcholine; Acetylcholine receptors; Acute respiratory distress syndrome; Direct anti-inflammatory effect; Low tidal volume ventilation; Lung injury markers; Neuromuscular blockers; Partial neuromuscular blockade; Respiratory muscles.

Publication types

  • Editorial

MeSH terms

  • Cholinergic Antagonists / pharmacology*
  • Cholinergic Antagonists / therapeutic use
  • Humans
  • Neuromuscular Nondepolarizing Agents / pharmacology
  • Neuromuscular Nondepolarizing Agents / therapeutic use
  • Respiratory Distress Syndrome / drug therapy*
  • Respiratory Distress Syndrome / physiopathology
  • Treatment Outcome

Substances

  • Cholinergic Antagonists
  • Neuromuscular Nondepolarizing Agents